Member access

4-Traders Homepage  >  Shares  >  Amex  >  Protalix BioTherapeutics Inc.    PLX   US74365A1016

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Amex
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
2.14(c) 2.015(c) 2.03(c) 1.98(c) 1.95(c) Last
262 426 160 529 89 419 457 694 87 524 Volume
+1.90% -5.84% +0.74% -2.46% -1.52% Change
More quotes
Company
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system.It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease.Its drug... 
More about the company
Surperformance© ratings of Protalix BioTherapeutics I
Trading Rating : Investor Rating :
More Ratings
Chart PROTALIX BIOTHERAPEUTICS I
Duration : Period :
Protalix BioTherapeutics I Technical Analysis Chart | PLX | US74365A1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 15,8 M
EBIT 2013 -19,9 M
Net income 2013 -19,0 M
Debt 2013 -
Yield 2013 -
Sales 2014 35,8 M
EBIT 2014 -12,9 M
Net income 2014 -4,70 M
Debt 2014 -
Yield 2014 -
PER 2013 -
PER 2014
Capi. / Sales 2013 11,6x
Capi. / Sales 2014 5,10x
Capitalization 183 M
More Financials
Latest news on PROTALIX BIOTHERAPEUTICS I
11/17 PROTALIX BIOTHERAPEUTICS : posts 3Q loss
11/12 PROTALIX BIOTHERAPEUTICS : Submission of Matters to a Vote of Security Holders (..
09/29 PROTALIX BIOTHERAPEUTICS : Change in Directors or Principal Officers, Financial ..
09/29 Protalix BioTherapeutics Appoints Moshe Manor as President and Chief Executiv..
09/04 PFIZER : and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indicat..
09/04 PROTALIX BIOTHERAPEUTICS : to Present at the Rodman & Renshaw 16th Annual Global..
09/03 PFIZER : FDA Approves Pediatric Indication for Elelyso (taliglucerase alfa)
08/29 PFIZER : and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indicat..
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF